+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mometasone"

Bronchodilators Global Market Report 2024 - Product Thumbnail Image

Bronchodilators Global Market Report 2024

  • Report
  • April 2024
  • 175 Pages
  • Global
From
Anti-Asthmatics and COPD Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Asthmatics and COPD Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Asthma Drugs Global Market Report 2024 - Product Thumbnail Image

Asthma Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Sinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
From
From
Drug Overview: QVM149 - Product Thumbnail Image

Drug Overview: QVM149

  • Report
  • February 2018
  • 15 Pages
  • Global
From
Drug Analysis: Dulera - Product Thumbnail Image

Drug Analysis: Dulera

  • Drug Pipelines
  • February 2018
  • 17 Pages
  • Global
From
Drug Overview: Dulera - Product Thumbnail Image

Drug Overview: Dulera

  • Report
  • February 2018
  • 17 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Mometasone is a corticosteroid drug used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is available in both topical and inhaled forms, and is used to reduce inflammation in the airways. It is often prescribed in combination with other drugs, such as bronchodilators, to provide more comprehensive relief. Mometasone is generally well-tolerated, but can cause side effects such as headaches, nausea, and throat irritation. The mometasone market is a subset of the larger respiratory drugs market, which includes a variety of treatments for respiratory conditions. The market is highly competitive, with a number of major pharmaceutical companies offering mometasone-based products. These include GlaxoSmithKline, Merck, Novartis, and Pfizer. Generic versions of mometasone are also available, providing an affordable alternative for patients. Show Less Read more